A novel podocyte gene, SEMA3G (semaphorin 3G) might contribute to ccRCC tumorigenesis by affecting Wnt pathway (Wang et al., 2023). The gene discussed is SEMA3G; the disease is nonpapillary renal cell carcinoma.